NCT00541359View on ClinicalTrials.gov

Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

Given IV

DRUG

topotecan hydrochloride

Given IV

OTHER

immunohistochemistry staining method

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (2)

91010

City of Hope Medical Center, Duarte

91105

City of Hope Medical Group Inc, Pasadena

All Listed Sponsors
lead

City of Hope Medical Center

OTHER

NCT00541359 - Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter